VIM
MRNA icon

Vinva Investment Management’s Moderna MRNA Stock Holding History

Vinva Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,925
Closed -$968K – 386
2023
Q2 		$968K Sell
7,925
-3,040
-28% -$406K 0.08% 239
2023
Q1 		$1.62M Buy
+10,965
New +$1.81M 0.13% 175

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Vinva Investment Management's MRNA Position: Q3 2023 in Review

Vinva Investment Management sold out of Moderna (MRNA) in Q3 2023, closing a stake of 7,925 shares — an estimated $968K sold.

Vinva Investment Management first reported a position in MRNA in Q1 2023 and held it in 2 quarters. The position peaked at $1.62M in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Vinva Investment Management reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Vinva Investment Management sold 7,925 Moderna shares in Q3 2023, an estimated $968K.
  • Vinva Investment Management first reported a position in Moderna in Q1 2023 and held it in 2 quarters.
  • Vinva Investment Management's Moderna position peaked at $1.62M in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Vinva Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.